Cathepsin B inhibition limits bone metastasis in breast cancer.
about
Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitorsCysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probesTargeting tumor-stromal interactions in bone metastasisCathepsin B promotes colorectal tumorigenesis, cell invasion, and metastasisCathepsin B Expression and the Correlation with Clinical Aspects of Oral Squamous Cell CarcinomaCell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progressionImaging Sites of Inhibition of Proteolysis in Pathomimetic Human Breast Cancer Cultures by Light-Activated Ruthenium CompoundOblongifolin C inhibits metastasis by up-regulating keratin 18 and tubulinsMurine models of breast cancer bone metastasisCathepsin S-mediated autophagic flux in tumor-associated macrophages accelerate tumor development by promoting M2 polarization.CathepsinĀ B expression in colorectal cancer in a Middle East population: Potential value as a tumor biomarker for late disease stages.Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer.Cathepsin L and B as Potential Markers for Liver Fibrosis: Insights From Patients and Experimental Models.Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targetsDroplet electrospray ionization mass spectrometry for high throughput screening for enzyme inhibitorsMolecular cloning and characterization of cystatin, a cysteine protease inhibitor, from bufo melanostictus.Activity of plasma membrane V-ATPases is critical for the invasion of MDA-MB231 breast cancer cells.N,N'-dinitrosopiperazine-mediated AGR2 is involved in metastasis of nasopharyngeal carcinomaDifferential Impact of Cysteine Cathepsins on Genetic Mouse Models of De novo Carcinogenesis: Cathepsin B as Emerging Therapeutic Target.Targeting Cathepsin B for Cancer Therapies.Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancerNon-invasive Imaging of Idiopathic Pulmonary Fibrosis Using Cathepsin Protease Probes.Expression profile of cathepsins indicates the potential of cathepsins B and D as prognostic factors in breast cancer patients.Schizophrenia-Associated hERG channel Kv11.1-3.1 Exhibits a Unique Trafficking Deficit that is Rescued Through Proteasome Inhibition for High Throughput ScreeningMicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling.Pathomimetic cancer avatars for live-cell imaging of protease activity.Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer.Skeletal metastasis: treatments, mouse models, and the Wnt signaling.Cathepsins mediate tumor metastasis.The natural compound oblongifolin C inhibits autophagic flux and enhances antitumor efficacy of nutrient deprivation.Cancer-associated lysosomal changes: friends or foes?Cathepsin B: multiple roles in cancer.Emerging drugs for the treatment of bone metastasis.Targeting the lysosome in cancer.Effects of Vacuolar H(+)-ATPase Inhibition on Activation of Cathepsin B and Cathepsin L Secreted from MDA-MB231 Breast Cancer Cells.Pathophysiological roles of proteases in gastrointestinal disease.Lysosomal Biology in Cancer.Microbial inhibitors of cysteine proteases.TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targets.Inactivation of tristetraprolin in chronic hypoxia provokes the expression of cathepsin B.
P2860
Q26771736-26725928-33E2-4627-9F31-3EED95A4CAE3Q26827307-0F00C515-3408-43B8-BB0B-FDD3982BD046Q27024561-2F45BD16-632B-4FF6-BB90-A6D948BE2FC4Q28259436-C3FDE55D-6086-4216-88C2-89DDAADF89A8Q28274479-30DD3F60-66E6-4FCD-846D-C19D11721A58Q28299475-3C63D965-B017-49ED-BB26-E6A61005D539Q28550925-6CFA5CD3-CFC8-4303-BC98-609AB535A5D9Q30650458-B73C0FF0-7770-4402-861D-19894E619CEBQ30828525-BC607FE8-D222-4C84-B369-61A1D4B6C77DQ33589216-FAA07AC9-2F0D-4C6C-B6D5-4E54E950C97EQ33721128-2582D253-E9BB-4411-8D98-39B3FD61EF0AQ33739233-005C38D5-3240-4F3E-94A8-5D737AC656C9Q33920338-8A7EA86B-500B-4BE9-89F8-FACFD492EE5EQ34023663-D12FE083-7186-4A72-882C-A44E630C1D19Q34193957-50350E06-7F68-49F1-B149-ACA3D6EF2610Q35008559-76D878D2-F380-444A-B9A2-837E2E8FB9CBQ35055604-A5F94238-413F-4C89-B283-A874AAEABCBDQ35143700-8C68EFB4-0F27-44E5-88C7-586DF029AE35Q36087869-5CFD8E76-F861-4181-9D0B-284453CB81A8Q36326605-14C7D458-F33A-47AF-B45C-BCADFC3E1063Q36413686-EB77FFBC-6075-49B4-AB20-18C1A904C2A5Q36501195-555863AC-0887-4E89-ABBC-6E5A90AAACBFQ36502689-16482FF5-B6B5-4DDB-B7B7-006E78F2FA4DQ36583015-BB64C452-1519-41E7-BAE1-A5047CD09A6EQ37156452-01080692-E7F6-4E6D-BE4B-317E154C0207Q37166691-836BE060-E720-4818-B9C3-B34AE0852673Q37282934-8F04C71D-1D5A-4684-AA7A-9089439D88B5Q37354085-EA12AE45-6D9A-46C1-841F-3F97A805B97CQ37376103-7EFE6323-45CB-41B0-A6C4-50AD723CCCE6Q37428784-EF301D06-ABDC-441C-8897-2D7698884382Q38025001-2450CFA4-EFE5-474B-9FB7-DFD9972DFE0DQ38200056-0120C9BC-8C8D-45C6-A467-161BF0A67DD7Q38538263-40B3B828-7883-4582-8D2A-A41EFFEB132CQ38645365-E5ECB0DB-1884-4FCF-8854-37D1D1DF9D86Q38647522-EB6F16BC-E83B-45A0-8598-1B22AFE5FF37Q38678675-55959FFE-047B-46DF-A1E7-1EA3CE5227BAQ38689342-9FC3F2EC-25C1-4D4E-A547-6C5DAE61BA6CQ38799069-035140C7-2669-46A5-8D15-0F4B32B818CCQ38920996-AE551A53-4D81-4FE9-B91B-8681DE058387Q38934467-FE9A4345-4EE4-4930-9CD9-52DE88406ACC
P2860
Cathepsin B inhibition limits bone metastasis in breast cancer.
description
2012 nĆ® lÅ«n-bĆ»n
@nan
2012幓ć®č«ę
@ja
2012幓č«ę
@yue
2012幓č«ę
@zh-hant
2012幓č«ę
@zh-hk
2012幓č«ę
@zh-mo
2012幓č«ę
@zh-tw
2012幓č®ŗę
@wuu
2012幓č®ŗę
@zh
2012幓č®ŗę
@zh-cn
name
Cathepsin B inhibition limits bone metastasis in breast cancer.
@ast
Cathepsin B inhibition limits bone metastasis in breast cancer.
@en
type
label
Cathepsin B inhibition limits bone metastasis in breast cancer.
@ast
Cathepsin B inhibition limits bone metastasis in breast cancer.
@en
prefLabel
Cathepsin B inhibition limits bone metastasis in breast cancer.
@ast
Cathepsin B inhibition limits bone metastasis in breast cancer.
@en
P2093
P2860
P50
P1433
P1476
Cathepsin B inhibition limits bone metastasis in breast cancer.
@en
P2093
Arulselvi Anbalagan
Bonnie F Sloane
Bradley N Bidwell
Clare Slaney
Galia Blum
Kamiar Moin
Mansoureh Sameni
Mary B Olive
Matthew S Bogyo
P2860
P304
P356
10.1158/0008-5472.CAN-11-2759
P407
P577
2012-01-19T00:00:00Z